Danish drugmaker Lundbeck has its eye on steady growth over the medium term, a strategy which new chief executive Charl van Zyl believes could be key to the fir 12 February 2024
Germany-based Vivoryon Therapeutics could well be on the path towards altering the course of Alzheimer’s disease (AD), with a PhII data readout coming up and a 9 February 2024
In an Expert View piece, Mark Seymour, Director and Head of Media at FleishmanHillard, argues that in the ever-evolving world of healthcare, the rules of commun 8 February 2024
An Expert View from Ross Maclean, Precision Health Economics, Outcomes Research and Head of Medical Affairs,Precision Value and Health, and the same company's J 5 February 2024
The life sciences landscape has adapted in tandem with data management solutions over the past several years.attracting significant investment.However. 3 January 2024
Last month, the European Commission (EC) approved Ebglyss (lebrikizumab) for the treatment of adult and adolescent patients with moderate-to-severe atopic derma 21 December 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.